Molecular Imaging of Alzheimer's Disease-Related Sigma-1 Receptor in the Brain via a Novel Ru-Mediated Aromatic 18 F-deoxyfluorination Probe.
Ping BaiFrederick A BagdasarianYulong XuYanli WangYongle WangAshley GommYanting ZhouRui WuHsiao-Ying WeyRudolph E TanziCan Martin ZhangYu LanChangning WangPublished in: Journal of medicinal chemistry (2024)
Sigma-1 receptor (σ 1 R) is an intracellular protein implicated in a spectrum of neurodegenerative conditions, notably Alzheimer's disease (AD). Positron emission tomography (PET) imaging of brain σ 1 R could provide a powerful tool for better understanding the underlying pathomechanism of σ 1 R in AD. In this study, we successfully developed a 18 F-labeled σ 1 R radiotracer [ 18 F]CNY-05 via an innovative ruthenium (Ru)-mediated 18 F-deoxyfluorination method. [ 18 F]CNY-05 exhibited preferable brain uptake, high specific binding, and slightly reversible pharmacokinetics within the PET scanning time window. PET imaging of [ 18 F]CNY-05 in nonhuman primates (NHP) indicated brain permeability, metabolic stability, and safety. Moreover, autoradiography and PET studies of [ 18 F]CNY-05 in the AD mouse model found a significantly decreased brain uptake compared to that in wild-type mice. Collectively, we have provided a novel 18 F-radiolabeled σ 1 R PET probe, which enables visualizing brain σ 1 R in health and neurological diseases.
Keyphrases
- pet imaging
- positron emission tomography
- resting state
- computed tomography
- white matter
- functional connectivity
- pet ct
- mouse model
- cerebral ischemia
- healthcare
- public health
- wild type
- type diabetes
- adipose tissue
- cognitive decline
- mental health
- binding protein
- endothelial cells
- skeletal muscle
- mass spectrometry
- reactive oxygen species
- health information
- human health
- subarachnoid hemorrhage